Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients
1 other identifier
interventional
49
1 country
1
Brief Summary
Aim: By application of wearable devices and health management platform to build self-management model in CKD patients and analyze the cost of healthcare. Material and Methods: The investigators plan to recruit 60 CKD patients as trial subjects. The intervention group is composed of 30 participants, and the control group 30 participants. The intervention group received intervention with wearable devices and health management platform for 90 days. Patients record diet diary by a smartphone application, and their exercise-related data are collected by wearable devices. Then, all the collected information will be upload to health management platform. The investigators also create a LINE group to encourage exercise in the experimental group. The investigators compare the scores of self-management sheet and physical and laboratory examinations before and after the intervention. The investigators also analyze the cost of healthcare within 180 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2020
CompletedFirst Submitted
Initial submission to the registry
June 7, 2020
CompletedFirst Posted
Study publicly available on registry
November 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedAugust 26, 2021
May 1, 2020
1.4 years
June 7, 2020
August 22, 2021
Conditions
Outcome Measures
Primary Outcomes (5)
Change from Baseline Self-efficacy at 3 months
the score of self-efficacy questionnaire (score 0-200, the higher the better) in units
(1) baseline, (2) after the 90-day intervention
Change from Baseline Self-management at 3 months
the score of self-management questionnaire (score 16-64, the higher the better) in units
(1) baseline, (2) after the 90-day intervention
Change from Baseline Quality of life score at 3 months
the score of Kidney Disease Quality of Life (KDQOL-SF™) questionnaire (score 74-360, the higher the better) in units
(1) baseline, (2) after the 90-day intervention
Change from Baseline Body composition at 3 month
weight and height will be combined to report BMI in kg/m\^2
(1) baseline, (2) after the 90-day intervention
Change from Baseline Renal function at 3 months
estimated glomerular filtration rate in mL/min/1.73m2
(1) baseline, (2) after the 90-day intervention
Study Arms (2)
Intervention group
EXPERIMENTALThe intervention involved reminding the intervention group to upload their dietary diary every day. The researchers were trained by a dietitian and provided suggestions about diet and exercise to the intervention group. "LINE " is a mobile app operated by LINE Corporation. All users can use texts, images, video, and audio for contact at any time. A LINE group was created to deliver medical knowledge of diet and exercise. Each of the messages were guided by a diet manual for kidney disease (edited by Department of Dietetics, National Taiwan University Hospital Yunlin Branch). The intervention group also asked questions about CKD management, and a teleconsultation of health information was provided. A daily target of 7,500 steps was set and used to emphasize the correct concepts about exercise. Participants were inspired in the intervention group if someone achieved the target number of steps.
Control group
NO INTERVENTIONThe participants of control group had a wearable device and could upload their dietary diary to the health management platform every day. But no "LINE" group was created, and no reminding.
Interventions
The intervention involved reminding the intervention group to upload their dietary diary every day. The researchers were trained by a dietitian and provided suggestions about diet and exercise to the intervention group. "LINE " is a mobile app operated by LINE Corporation. All users can use texts, images, video, and audio for contact at any time. A LINE group was created to deliver medical knowledge of diet and exercise. Each of the messages were guided by a diet manual for kidney disease (edited by Department of Dietetics, National Taiwan University Hospital Yunlin Branch). The intervention group also asked questions about CKD management, and a teleconsultation of health information was provided. A daily target of 7,500 steps was set and used to emphasize the correct concepts about exercise. Participants were inspired in the intervention group if someone achieved the target number of steps.
Eligibility Criteria
You may qualify if:
- Chronic kidney disease stage 1-4
- Agree to partake in the study signed informed consent forms for participation.
You may not qualify if:
- Can not use a smartphone
- Have impaired walking capacity
- Psychiatric disorder
- Have been hospitalized during the previous three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital Yunlin Branch
Douliu, 640, Taiwan
Related Publications (1)
Li WY, Chiu FC, Zeng JK, Li YW, Huang SH, Yeh HC, Cheng BW, Yang FJ. Mobile Health App With Social Media to Support Self-Management for Patients With Chronic Kidney Disease: Prospective Randomized Controlled Study. J Med Internet Res. 2020 Dec 15;22(12):e19452. doi: 10.2196/19452.
PMID: 33320101DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wen-Yi Li
National Taiwan University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2020
First Posted
November 5, 2020
Study Start
January 13, 2019
Primary Completion
May 31, 2020
Study Completion
December 31, 2020
Last Updated
August 26, 2021
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share